U.S. markets closed
  • S&P 500

    4,173.85
    +61.35 (+1.49%)
     
  • Dow 30

    34,382.13
    +360.68 (+1.06%)
     
  • Nasdaq

    13,429.98
    +304.99 (+2.32%)
     
  • Russell 2000

    2,224.63
    +53.68 (+2.47%)
     
  • Crude Oil

    65.51
    +1.69 (+2.65%)
     
  • Gold

    1,844.00
    +20.00 (+1.10%)
     
  • Silver

    27.50
    +0.46 (+1.69%)
     
  • EUR/USD

    1.2146
    +0.0062 (+0.51%)
     
  • 10-Yr Bond

    1.6350
    -0.0330 (-1.98%)
     
  • GBP/USD

    1.4102
    +0.0050 (+0.36%)
     
  • USD/JPY

    109.3470
    -0.0870 (-0.08%)
     
  • BTC-USD

    49,661.62
    +61.03 (+0.12%)
     
  • CMC Crypto 200

    1,398.33
    +39.77 (+2.93%)
     
  • FTSE 100

    7,043.61
    +80.28 (+1.15%)
     
  • Nikkei 225

    28,084.47
    +636.46 (+2.32%)
     

/C O R R E C T I O N -- Ellomay Capital Ltd/

  • Oops!
    Something went wrong.
    Please try again later.
·24 min read
  • Oops!
    Something went wrong.
    Please try again later.

In the news release, Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2020, issued 31-Mar-2021 by Ellomay Capital Ltd over PR Newswire, we are advised by the company that there were a few errors in their tables as originally issued inadvertently. The complete, corrected release follows:

Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2020

TEL AVIV, Israel, April 1, 2021 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported its unaudited financial results for the fourth quarter and year ended December 31, 2020.

Financial Highlights

  • Revenues were approximately €9.6 million for the year ended December 31, 2020, compared to approximately €19 million for the year ended December 31, 2019. The decrease is mainly due to the sale of the Company's Italian PV portfolio (the "Italian PV Portfolio") in December 2019. 2020 revenues were also impacted by the decrease in demand and prices of the European electricity markets due to the Covid-19 pandemic, partially offset by an increase in revenues in one of the Company's biogas plants in the Netherlands resulting from increased operational efficiency.

  • Operating expenses were approximately €5 million for the year ended December 31, 2020, compared to approximately €6.6 million for the year ended December 31, 2019. The decrease in operating expenses is mainly attributable to the sale of the Italian PV Portfolio, to increased operational efficiency of the Company's biogas plants in the Netherlands and to insurance reimbursement in connection with the storm damages in one of the Company's biogas plants in the Netherlands that reduced operating expenses. Depreciation expenses were approximately €3 million for the year ended December 31, 2020, compared to approximately €6.4 million for the year ended December 31, 2019.

  • Project development costs were approximately €3.5 million for the year ended December 31, 2020, compared to approximately €4.2 million for the year ended December 31, 2019. The decrease in project development costs is mainly due to a decrease in consultancy expenses for the Company's development project of a 156 MW pumped storage project in the Manara Cliff in Israel (the "Manara PSP"), partially offset by consultancy expenses in connection with the development of new photovoltaic projects in Italy.

  • General and administrative expenses were approximately €4.5 million for the year ended December 31, 2020, compared to approximately €3.8 million for the year ended December 31, 2019. The increase in general and administrative expenses resulted mainly from a higher cost of the Company's D&O liability insurance.

  • Company's share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €1.5 million for the year ended December 31, 2020, compared to approximately €3.1 million for the year ended December 31, 2019. The decrease in the share of profit of equity accounted investee is mainly attributable to the decrease in the revenues of Dorad Energy Ltd. ("Dorad") mainly due to a decrease in tariff and in the electricity sold to Dorad's customers for the year ended December 31, 2020, partially offset by lower financing expenses incurred by Dorad as a result of the CPI indexation of loans from banks.

  • Other income, net, was approximately €2.1 million in the year ended December 31, 2020, compared to other expenses, net, of approximately €2.1 million in the year ended December 31, 2019. During 2019, the Company recorded expenses in the amount of approximately €2.1 million in connection with the announcement received from GSE, Italy's energy regulation agency, by one of the Company's Italian subsidiaries, claiming alleged non-compliance of the installed modules with the required certifications under the applicable regulation and raising the need to examine incentive eligibility implications (the "GSE Claim"). On December 20, 2019, the Company sold its holdings in this subsidiary. The Sale and Purchase Agreement governing the sale of the subsidiary provided for up to €2.1 million of indemnification in connection with the GSE Claim and the Company recorded this potential payment as other expenses. In 2020, with the cooperation of the acquirer of the Italian subsidiaries, an appeal was submitted to GSE. Following the positive outcomes of such appeal, the provision for the potential indemnification was cancelled.

  • Capital gain was 0 in the year ended December 31, 2020, compared to approximately €18.8 million in the year ended December 31, 2019. The capital gain in the year ended December 31, 2019 was recorded in connection with the sale of the Italian PV Portfolio on December 20, 2019.

  • Financing expenses, net was approximately €3.6 million for the year ended December 31, 2020, compared to approximately €8.2 million for the year ended December 31, 2019. The decrease in financing expenses, net, was mainly attributable to lower interest expenses due to the early repayment of the Company's Series A Debentures and the sale of the Italian PV Portfolio, including all related project finance.

  • Tax benefit was approximately €0.1 million in the year ended December 31, 2020, compared to tax benefit of approximately €0.3 million in the year ended December 31, 2019.

  • Net loss was approximately €6.2 million in the year ended December 31, 2020, compared to net profit of approximately €9.8 million for the year ended December 31, 2019.

  • Total other comprehensive income was approximately €2.3 million for the year ended December 31, 2020, compared to total other comprehensive income of approximately €1.3 million in the year ended December 31, 2019. The change was mainly due to changes in fair value of cash flow hedges and from foreign currency translation differences on New Israeli Shekel denominated operations, due to fluctuations in the euro/NIS exchange rates.

  • Total comprehensive loss was approximately €3.9 million in the year ended December 31, 2020, compared to total comprehensive profit of approximately €11 million in the year ended December 31, 2019.

  • EBITDA was approximately €0.3 million for the year ended December 31, 2020, compared to approximately €24.1 million (including €18.8 million capital gain recorded in connection of the sale of the Italian PV Portfolio) for the year ended December 31, 2019.

  • Net cash used in operating activities was approximately €5.8 million for the year ended December 31, 2020, compared to approximately €3.7 million provided from operating activities for the year ended December 31, 2019.

  • The Talasol PV Plant reached mechanical completion in September 2020 and was connected to the electricity grid and electricity production commenced at the end of December 2020. PAC was achieved on January 27, 2021.

  • On February 23, 2021, the Company issued additional Series C Debentures in a public offering in Israel in an aggregate principal amount of NIS 100.939 million (approximately €25.6 million based on the euro/NIS exchange rate as of December 31, 2020). The gross proceeds from the offering were NIS 102.4 million and the net proceeds of the offering, net of related expenses such as consultancy fee and commissions, were approximately NIS 101.5 million (approximately €25.7 million based on the euro/NIS exchange rate as of December 31, 2020).

  • On February 23, 2021, the Company issued a new Series D Convertible Debentures in a public offering in Israel in the aggregate principal amount of NIS 62 million (approximately €15.7 million based on the euro/NIS exchange rate as of December 31, 2020). The principal amount of the Series D Debentures is repayable in one installment on December 31, 2026. The Series D Debentures bear a fixed interest at the rate of 1.2% per year (that is not linked to the Israeli CPI or otherwise), payable semi-annually on June 30 and December 31 commencing June 30, 2021 through December 31, 2026 (inclusive). The Series D Debentures are convertible into the Company's ordinary shares, NIS 10.00 par value per share, at a conversion price of NIS 165 (approximately €41.8 based on the euro/NIS exchange rate as of December 31, 2020), subject to adjustments upon customary terms. The Series D Debentures are not rated. The gross proceeds from the offering were approximately NIS 62.6 million and the net proceeds of the offering, net of related expenses such as consultancy fee and commissions, were approximately NIS 61.8 million (approximately €15.7 million based on the euro/NIS exchange rate as of December 31, 2020).

  • As of March 1, 2021, the Company held approximately €125 million in cash and cash equivalents, approximately €1.76 million in marketable securities and approximately €10 million in restricted long-term cash.

  • On March 18, 2021, the Company's Series B Debentures were repaid in full. Pursuant to the terms of the deed of trust governing the Series B Debentures, the early repayment consisted of a principal payment in the amount of approximately NIS 86.3 million (approximately €21.5 million), accrued interest in the amount of approximately NIS 0.7 million (approximately €0.16 million) and a prepayment charge of approximately NIS 3.4 million (approximately €0.86 million), amounting to an aggregate repayment amount of approximately NIS 90.4 million (approximately €22.5 million).

  • On February 11, 2021, the Manara PSP Project Finance reached financial closing. The Manara PSP Project Finance will be provided by a consortium of Israeli banks and institutional investors, arranged and led by Mizrahi-Tefahot Bank Ltd. The Manara PSP Project Finance is in the aggregate amount of NIS 1.18 billion (approximately €300 million based on the euro/NIS exchange rate as of December 31, 2020), and includes: (i) a Senior Secured Tranche at a fixed rate of interest for each drawdown, with base interest rate equal to the yield to maturity of Israeli treasury bonds with like duration of the loan drawdown, plus a spread of 3.25% per-annum during the Construction Period of the Project and a spread of 2.40% per-annum from the Actual Completion Date of the Project which proceeds the Commercial Operation Date of the Project. The Senior Secured Tranche is linked to the Israeli Consumer Price Index and is to be repaid over a period of 19.5 years from the commercial operation date; and (ii) a Subordinated Secured B Tranche at a floating rate of interest, with the base interest being the Bank of Israel rate, plus a spread of 4.35% per-annum during the Construction Period and a spread of 3.90% per-annum from the Actual Completion Date. The stated maturity of the Tranche B loan is one year less than the maturity of the Senior Secured Loan with a cash sweep mechanism that shortens its maturity to approximately 12 years from the Commercial Operation Date under the Base Case Financial Model.

  • In connection with the Manara PSP Project Finance that occurred on February 2021, and based on the A.R.Z. Settlement Agreement, A.R.Z. was required to provide its indirect share of equity investment and financing to the Manara PSP. Due to the failure to provide the required funds, Ellomay Water Plants Holdings (2014) Ltd., the Company's wholly-owned subsidiary that holds 75% of Ellomay PS, seized E.R.Z.'s holdings in Sheva Mizrakot (33%) and, as a result, the Company's indirect holdings in the Manara PSP increased from 75% to 83.333% in January 2021.

Shlomo Nehama, Chairmen of the Board of Ellomay, commented: "Ellomay Capital operates in one of the developing sectors around the world in the renewable energy field, a market that is expanding and growing.

Ellomay Capital raised funds during the year through issuances of equity and debt in order to expand its operations. In addition, Ellomay Capital has made tremendous advancements during this year, primarily the completion of construction and the commercial operation of the Talasol project that has an installed capacity of 300 MW and that is a large project in a European scale, positioning Ellomay as a leading developer in the renewable energy field. In addition, after a lengthy effort of several years, the Company succeeded in reaching the financial closing and receiving regulatory approval for the construction of the pumped storage project in the Manara Cliff, Israel, which is a central project in the future electricity plans of the State of Israel. In addition to these projects the Company succeeded in advancing and materially improving the operational efficiency of its Biogas projects in the Netherlands. The results of such achievements will be evident in the next year and over the coming years.

I would like to thank Ellomay's professional team, led by Ran Fridrich, for all their hard work and efforts and for, in spite of the objective difficulties of the Covid-19 pandemic, succeeded in advancing these two significant projects."

Ran Fridrich, CEO and a board member of Ellomay, further commented: "2020 was a challenging transition year for Ellomay Capital. The portfolio of photovoltaic projects in Italy, which was based on governmental subsidies, was sold at the end of 2019 for a substantial capital gain. This portfolio provided annual revenues of approximately €9 million, which were not part of the Company's revenues for 2020.

2020 was a year in which new significant projects were built or purchased (the Talasol project in Spain and a biogas project in the Netherlands) and their contribution to the Company's revenues and income will only become part of the Company's results during 2021.

In parallel to the construction of the Talasol project, the Company concluded the financial closing of the pumped storage project "Manara Cliff" and the development of the smaller photovoltaic project in Talasol (28 MW), which has already commenced the construction phase, and reached substantial advancements in the development of the pipeline of new Italian photovoltaic projects, with 90 MW expected to receive a construction permit during 2021. The operational improvements of the Netherlands' biogas plants continued and a new biogas plant that was acquired in December 2020 was successfully added to the operations.

A delay of approximately a quarter in the connection with the Talasol plant to the electricity grid that according to the Spanish grid company was due to Covid-19 implications caused a deviation of approximately €5 million from the projected revenues for 2020. The Company's projections for 2021 are based mainly on the operating assets (approximately 85% of the projections) and only a small portion is based on assets that are expected to be built during 2021.

The Company is developing a large pipeline of photovoltaic projects in Spain and Italy, all self-developed from the initial stages, and a large portion of them (over 400 MW) are in advanced development stages and are expected to be built during the next two and a half years. In addition, the Company is advancing the process of obtaining building permits for the PV plus storage projects in Israel that the Company won in the first storage tender in Israel.

As noted, 2020 was a challenging year but the Company met all of its goals mainly due to the dedication and high abilities of each one of its employees."

Use of NON-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's historical financial performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures, and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measures presented by other companies. The Company's EBITDA may not be indicative of the historic operating results of the Company; nor is it meant to be predictive of potential future results. A reconciliation between results on an IFRS and non-IFRS basis is provided in the last table of this press release.

About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:

  • Approximately 7.9MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9 MW in Israel;

  • 9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel's largest private power plants with production capacity of approximately 860MW, representing about 6%-8% of Israel's total current electricity consumption;

  • 51% of Talasol, which owns a photovoltaic plant with a peak capacity of 300MW in the municipality of Talaván, Cáceres, Spain;

  • Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million (with a license to produce 7.5 million) Nm3 per year, respectively;

  • 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including the impact of the Covid-19 pandemic on the Company's operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, changes in the market price of electricity and in demand, regulatory changes, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, and technical and other disruptions in the operations or construction of the power plants owned by the Company. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Kalia Weintraub
CFO
Tel: +972 (3) 797-1111
Email: hilai@ellomay.com

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Financial Position


December 31,


2020

2019

2020


Audited

Audited

Audited


€ in thousands

Convenience Translation into
US$ in thousands*

Assets




Current assets:




Cash and cash equivalents

66,845

44,509

82,004

Marketable securities

1,761

2,242

2,160

Short term deposits

8,113

6,446

9,953

Restricted cash

-

22,162

-

Receivable from concession project

1,491

1,463

1,829

Financial assets

-

1,418

-

Trade and other receivables

9,825

4,882

12,053


88,035

83,122

107,999

Non-current assets




Investment in equity accounted investee

32,234

33,561

39,544

Advances on account of investments

2,423

883

2,972

Receivable from concession project

25,036

27,122

30,714

Fixed assets

264,095

114,389

323,987

Right-of-use asset

17,209

15,401

21,112

Intangible asset

4,604

5,042

5,648

Restricted cash and deposits

9,931

10,956

12,183

Deferred tax

3,605

2,285

4,423

Long term receivables

2,762

12,249

3,388

Derivatives

10,238

5,162

12,560


372,137

227,050

456,531





Total assets

460,172

310,172

564,530





Liabilities and Equity




Current liabilities




Current maturities of long term bank loans

10,232

4,138

12,552

Current maturities of long term loans

4,021

-

4,933

Debentures

10,600

26,773

13,004

Trade payables

12,387

1,765

15,197

Other payables

7,912

5,010

9,706


45,152

37,686

55,392

Non-current liabilities




Lease liability

17,299

15,402

21,222

Long-term loans

134,520

40,805

165,027

Other long-term bank loans

49,396

48,377

60,598

Debentures

72,124

44,811

88,480

Deferred tax

7,806

6,467

9,576

Other long-term liabilities

513

1,795

629

Derivatives

8,336

7,263

10,226


289,994

164,920

355,758

Total liabilities

335,146

202,606

411,150

Equity




Share capital

25,102

21,998

30,795

Share premium

82,401

64,160

101,088

Treasury shares

(1,736)

(1,736)

(2,130)

Transaction reserve with non-controlling Interests

6,106

6,106

7,491

Reserves

4,164

3,283

5,108

Retained earnings

8,191

12,818

10,049

Total equity attributed to shareholders of the Company

124,228

106,629

152,401

Non-Controlling Interest

798

937

979

Total equity

125,026

107,566

153,380

Total liabilities and equity

460,172

310,172

564,530

* Convenience translation into US$ (exchange rate as at December 31, 2020: euro 1 = US$ 1.227)
** Reclassified

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Financial Position


For the three months ended December 31,

For the year

ended December 31,

For the three months ended December 31,

For the year ended December 31,



2020

2019

2020

2019

2020

2020


Unaudited

Audited

Unaudited

Audited


in thousands

Convenience Translation into US$*

Revenues

2,801

3,553

9,645

18,988

3,436

11,832

Operating expenses

(1,541)

(1,589)

(4,951)

(6,638)

(1,890)

(6,074)

Depreciation and amortization expenses

(731)

(1,702)

(2,975)

(6,416)

(897)

(3,650)

Gross profit

529

262

1,719

5,934

649

2,108








Project development costs

(479)

(742)

(3,491)

(4,213)

(588)

(4,283)

General and administrative expenses

(1,186)

(969)

(4,512)

(3,827)

(1,455)

(5,535)

Share of profits of equity accounted investee

(380)

704

1,525

3,086

(466)

1,871

Other income (expenses), net

2,100

(2,100)

2,100

(2,100)

2,576

2,576

Capital gain

-

18,770

-

18,770

-

-

Operating profit (loss)

584

15,925

(2,659)

17,650

716

(3,263)








Financing income

802

385

2,134

1,827

984

2,618

Financing income (expenses) in connection with derivatives,
net

(438)

(98)

1,094

897

(537)

1,342

Financing expenses

(1,708)

(3,828)

(6,862)

(10,877)

(2,095)

(8,418)

Financing expenses, net

(1,344)

(3,541)

(3,634)

(8,153)

(1,648)

(4,458)

Profit before taxes on income

(760)

12,384

(6,293)

9,497

(932)

(7,721)

Tax benefit (Taxes on income)

285

1,200

125

287

350

153

Profit (loss) for the period

(475)

13,584

(6,168)

9,784

(582)

(7,568)

Profit (loss) attributable to:


-





Owners of the Company

(216)

13,683

(4,627)

12,060

(265)

(5,676)

Non-controlling interests

(259)

(99)

(1,541)

(2,276)

(318)

(1,892)

Profit (loss) for the period

(475)

13,584

(6,168)

9,784

(583)

(7,568)

Other comprehensive income (loss) items







That after initial recognition in comprehensive
income (loss) were or will be transferred to profit or loss:







Foreign currency translation differences for foreign operations

801

(696)

(482)

2,103

983

(591)

Effective portion of change in fair value of cash flow hedges

(1,443)

(12,213)

2,210

1,076

(1,770)

2,711

Net change in fair value of cash flow hedges transferred to

profit or loss

(163)

356

555

(1,922)

(200)

681

Total other comprehensive profit (loss)

(805)

(12,553)

2,283

1,257

(987)

2,801








Total other comprehensive income (loss) attributable to:







Owners of the Company

87

(6,286)

881

2,114

107

1,081

Non-controlling interests

(892)

(6,267)

1,402

(857)

(1,094)

1,720

Total other comprehensive income (loss)

(805)

(12,553)

2,283

1,257

(987)

2,801








Total comprehensive income (loss) for the year

(1,280)

1,031

(3,885)

11,041

(1,570)

(4,767)








Total comprehensive income (loss) for the year attributable to:







Owners of the Company

(129)

7,397

(3,746)

14,174

(158)

(4,595)

Non-controlling interests

(1,151)

(6,366)

(139)

(3,133)

(1,412)

(172)

Total comprehensive income (loss) for the year

(1,280)

1,031

(3,885)

11,041

(1,570)

(4,767)








Basic earnings (loss) per share

(0.01)

1.19

(0.38)

1.09

(0.01)

(0.47)

Diluted earnings (loss) per share

(0.01)

1.19

(0.38)

1.09

(0.01)

(0.47)

* Convenience translation into US$ (exchange rate as at December 31, 2020: euro 1 = US$ 1.227)


Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Changes in Equity (in thousands)




Attributable to shareholders of the Company

Non- controlling

Total




Interests

Equity


Share capital

Share premium

Retained earnings

Treasury shares

Translation reserve from

foreign operations

Hedging Reserve

Interests Transaction reserve with

non-controlling Interests

Total




in thousands

For the year ended











December 31, 2020 (Audited):











Balance as at January 1, 2020

21,998

64,160

12,818

(1,736)

4,356

(1,073)

6,106

106,629

937

107,566

Profit (loss) for the year

-

-

(4,627)

-

-

-

-

(4,627)

(1,541)

(6,168)

Other comprehensive loss for the year

-

-

-

-

(533)

1,414

-

881

1,402

2,283

Total comprehensive loss for the year

-

-

(4,627)

-

(533)

1,414

-

(3,746)

(139)

(3,885)

Transactions with owners of the Company, recognized directly in equity:











Issuance of ordinary shares

3,084

18,191

-

-

-

-

-

21,275

-

21,275

Options exercise

20

-

-

-

-

-

-

20

-

20

Share-based payments

-

50

-

-

-

-

-

50

-

50

Balance as at











December 31, 2020

25,102

82,401

8,191

(1,736)

3,823

341

6,106

124,228

798

125,026












For the three months











ended December 31, 2020 (Unaudited):











Balance as at September 30, 2020

25,102

82,379

8,407

(1,736)

2,963

1,114

6,106

124,335

1,949

126,284

Profit (loss) for the year

-

-

(216)

-

-

-

-

(216)

(259)

(475)

Other comprehensive loss for the year

-

-

-

-

860

(773)

-

87

(892)

(805)

Total comprehensive loss for the year

-

-

(216)

-

860

(773)

-

(129)

(1,151)

(1,280)

Transactions with owners of the Company, recognized directly in equity:











Issuance of ordinary shares

-

-

-

-

-

-

-

-

-

-

Options exercise

-

-

-

-

-

-

-

-

-

-

Share-based payments

-

22

-

-

-

-

-

22

-

22

Balance as at











December 31, 2020

25,102

82,401

8,191

(1,736)

3,823

341

6,106

124,228

798

125,026

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)




Attributable to shareholders of the Company

Non- controlling

Total




Interests

Equity


Share capital

Share premium

Retained earnings

Treasury shares

Translation reserve from

foreign operations

Hedging Reserve

Interests Transaction reserve with

non-controlling Interests

Total




in thousands

For the year ended











December 31, 2019 (Audited):











Balance as at











January 1, 2019

19,980

58,344

758

(1,736)

1,396

(227)

-

78,515

(1,558)

76,957

Profit (loss) for the year

-

-

12,060

-

-

-

-

12,060

(2,276)

9,784

Other comprehensive income for the year

-

-

-

-

2,960

(846)

-

2,114

(857)

1,257

Total comprehensive income for the year

-

-

12,060

-

2,960

(846)

-

14,174

(3,133)

11,041

Transactions with owners of the Company, recognized directly in equity:











Sale of shares in subsidiaries to



...







non-controlling interests

-

-

-

-

-

-

5,439

5,439

5,374

10,813

Purchase of shares in subsidiaries from











non-controlling interests

-

-

-

-

-

-

667

667

254

921

Issuance of ordinary shares

2,010

5,797

-

-

-

-

-

7,807

-

7,807

Options exercise

8

11

-

-

-

-

-

19

-

19

Share-based payments

-

8

-

-

-

-

-

8

-

8

Balance as at











December 31, 2019

21,998

64,160

12,818

(1,736)

4,356

(1,073)

6,106

106,629

937

107,566












For the three months











ended December 31, 2019 (Unaudited):











Balance as at











September 30, 2019

21,998

64,155

(865)

(1,736)

5,097

4,472

6,106

99,227

7,303

106,530

Profit (loss) for the period

-

-

13,683

-

-

-

-

13,683

(99)

13,584

Other comprehensive loss for the period

-

-

-

-

(741)

(5,545)

-

(6,286)

(6,267)

(12,553)

Total comprehensive income for the period

-

-

13,683

-

(741)

(5,545)

-

7,397

(6,366)

1,031

Transactions with owners of the Company, recognized directly in equity:











Share-based payments

-

5

-

-

-

-

-

5

-

5

Balance as at











December 31, 2019

21,998

64,160

12,818

(1,736)

4,356

(1,073)

6,106

106,629

937

107,566

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)




Attributable to shareholders of the Company

Non- controlling

Total




Interests

Equity


Share capital

Share premium

Retained earnings

Treasury shares

Translation reserve from

foreign operations

Hedging Reserve

Interests Transaction reserve with

non-controlling Interests

Total




Convenience translation into US$ (exchange rate as at December 31, 2020: euro 1 = US$ 1.227)

For the year ended











December 31, 2020 (Audited):











Balance as at January 1, 2020

26,987

78,711

15,725

(2,130)

5,343

(1,316)

7,491

130,811

1,151

131,962

Profit (loss) for the year

-

-

(5,676)

-

-

-

-

(5,676)

(1,892)

(7,568)

Other comprehensive loss for the year

-

-

-

-

(654)

1,735

-

1,081

1,720

2,801

Total comprehensive loss for the year

-

-

(5,676)

-

(654)

1,735

-

(4,595)

(172)

(4,767)

Transactions with owners of the Company, recognized directly in equity:











Issuance of ordinary shares

3,783

22,316

-

-

-

-

-

26,099

-

26,099

Options exercise

25

-

-

-

-

-

-

25

-

25

Share-based payments

-

61

-

-

-

-

-

61

-

61

Balance as at











December 31, 2020

30,795

101,088

10,049

(2,130)

4,689

419

7,491

152,401

979

153,380












For the three months











ended December 31, 2020 (Unaudited):











Balance as at September 30, 2020

30,795

101,061

10,314

(2,130)

3,634

1,367

7,491

152,532

2,391

154,923

Profit (loss) for the year

-

-

(265)

-

-

-

-

(265)

(318)

(583)

Other comprehensive loss for the year

-

-

-

-

1,055

(948)

-

107

(1,094)

(987)

Total comprehensive loss for the year

-

-

(265)

-

1,055

(948)

-

(158)

(1,412)

(1,570)

Transactions with owners of the Company, recognized directly in equity:











Issuance of ordinary shares

-

-

-

-

-

-

-

-

-

-

Options exercise

-

-

-

-

-

-

-

-

-

-

Share-based payments

-

27

-

-

-

-

-

27

-

27

Balance as at











December 31, 2020

30,795

101,088

10,049

(2,130)

4,689

419

7,491

152,401

979

153,380


Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Cash Flow (in thousands)


For the three months ended December 31,

For the year ended December 31,

For the three months ended December 31,

For the year ended December 31,


2020

2019

2020

2019

2020

2020


Unaudited

Audited

Unaudited

Audited


in thousands

Convenience Translation into US$*

Cash flows from operating activities







Profit for the period

(475)

13,584

(6,168)

9,784

(582)

(7,568)

Adjustments for:







Financing expenses, net

1,344

3,541

3,634

8,153

1,648

4,458

Capital gain

-

(18,770)

-

(18,770)

-

-

Depreciation and amortization

731

1,702

2,975

6,416

897

3,650

Share-based payment transactions

22

5

50

8

27

61

Share of profits of equity accounted investees

380

(704)

(1,525)

(3,086)

466

(1,871)

Payment of interest on loan from an equity accounted investee

-

-

582

370

-

714

Change in trade receivables and other receivables

(3,137)

1,305

(3,868)

403

(3,848)

(4,745)

Change in other assets

(205)

(480)

179

(1,950)

(251)

220

Change in receivables from concessions project

203

200

1,426

1,329

249

1,749

Change in accrued severance pay, net

-

1

-

9

-

-

Change in trade payables

529

47

190

461

649

233

Change in other payables

(2,063)

2,646

(1,226)

5,336

(2,531)

(1,504)

Income tax expense (tax benefit)

(285)

(1,200)

(125)

(287)

(350)

(153)

Income taxes paid

(31)

(81)

(119)

(100)

(38)

(146)

Interest received

761

438

2,075

1,719

934

2,546

Interest paid

(1,325)

(2,846)

(3,906)

(6,083)

(1,625)

(4,792)


(3,076)

(14,196)

342

(6,072)

(3,773)

420

Net cash from (used in) operating activities

(3,551)

(612)

(5,826)

3,712

(4,355)

(7,148)

Cash flows from investing activities







Acquisition of fixed assets

(24,742)

(18,752)

(128,420)

(74,587)

(30,353)

(157,543)

Acquisition of subsidiary, net of cash acquire

(7,464)

-

(7,464)

(1,000)

(9,157)

(9,157)

Compensation as per agreement with Erez Electricity Ltd.

-

-

1,418

-

-

1,740

Repayment of loan from an equity accounted investee

55

-

1,978

-

67

2,427

Loan to an equity accounted investee

(181)

-

(181)

-

(222)

(222)

Proceeds from sale of investments

-

34,586

-

34,586

-

-

Advances on account of investments

-

-

(1,554)

-

-

(1,906)

Proceeds from marketable securities

436

-

1,800

-

535

2,208

Acquisition of marketable securities

(1,481)

-

(1,481)

-

(1,817)

(1,817)

Proceeds from settlement of derivatives, net

-

-

-

532

-

-

Proceed (investment) in restricted cash, net

742

(22,140)

23,092

(26,003)

910

28,329

Investment in short term deposit

84

-

(1,323)

(6,302)

103

(1,623)

Repayment (grant) Loan to others

-

-

-

3,912

-

-

Net cash used in investing activities

(32,551)

(6,306)

(112,135)

(68,862)

(39,934)

(137,564)

Cash flows from financing activities







Issuance of warrants

2,224

-

2,544

-

2,728

3,121

Repayment of long-term loans and finance lease obligations

(1,193)

212

(3,959)

(5,844)

(1,464)

(4,857)

Repayment of Debentures

-

(5,304)

(26,923)

(9,836)

-

(33,029)

Cost associated with long term loans

(734)

(12,218)

(734)

(12,218)

(900)

(900)

Proceeds from options

-

-

20

19

-

25

Sale of shares in subsidiaries to non-controlling interests

-

-

-

13,936

-

-

Acquisition of shares in subsidiaries from non-controlling

interests

-

-

-

(2,961)

-

-

Issuance of ordinary shares

-

-

21,275

7,807

-

26,100

Proceeds from long term loans, net

9,520

212

111,357

59,298

11,679

136,611

Proceeds from issuance of Debentures, net

38,057

-

38,057

22,317

46,688

46,688

Net cash from (used in) financing activities

47,874

(18,744)

141,637

72,518

58,731

173,759








Effect of exchange rate fluctuations on cash and cash equivalents

1,084

(637)

(1,340)

259

1,330

(1,646)

Increase (decrease) in cash and cash equivalents

12,856

(26,299)

22,336

7,627

15,771

27,401

Cash and cash equivalents at the beginning of the period

53,989

70,808

44,509

36,882

66,233

54,603

Cash and cash equivalents at the end of the period

66,845

44,509

66,845

44,509

82,004

82,004

* Convenience translation into US$ (exchange rate as at December 31, 2020: euro 1 = US$ 1.227)


Ellomay Capital Ltd. and its Subsidiaries

Reconciliation of Profit (Loss) to EBITDA (in thousands)


For the three months
ended December 31,

For the year ended
December 31,

For the three
months ended
December 31,

For the year
ended
December 31,


2020

2019

2020

2019

2020

2020


Unaudited


in thousands

Convenience Translation into US$*

Net profit (loss) for the period

(475)

13,584

(6,168)

9,784

(583)

(7,568)

Financing expenses, net

1,344

3,541

3,634

8,153

1,648

4,458

Taxes on income (tax benefit)

(285)

(1,200)

(125)

(287)

(350)

(153)

Depreciation and amortization

731

1,702

2,975

6,416

897

3,650

EBITDA

1,315

17,627

316

24,066

1,612

387

* Convenience translation into US$ (exchange rate as at December 31, 2020: euro 1 = US$ 1.227)

Information for the Company's Debenture Holders

Pursuant to the Deeds of Trust governing the Company's Series C and Series D Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Item 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on April 7, 2020 and below.

Net Financial Debt

As of December 31, 2020, the Company's Net Financial Debt (as such term is defined in the Deeds of Trust of the Company's Debentures) was approximately €6.2 million (consisting of approximately €207.9 million of short-term and long-term debt from banks and other interest bearing financial obligations and approximately €82.7 million in connection with the Series C Debentures issuances (in July 2019 and October 2020), net of approximately €76.7 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €207.7 million* of project finance and related hedging transactions of the Company's subsidiaries).

_____________________________
* The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders' loans to the project companies).

Information for the Company's Series C Debenture Holders
The Deed of Trust governing the Company's Series C Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of December 31, 2020, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's shareholders' equity was approximately €127.7 million and (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's consolidated shareholders' equity plus the Net Financial Debt) was 4.7% and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA(1) was 1.8.

______________________________________________
(1) The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef project, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

The following is a reconciliation between the Company's profit (loss) and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended December 31, 2020:


For the four
quarter period
ended December 31,
2020


Unaudited


in thousands

Profit (loss) for the period

(6,168)

Financing expenses, net

3,634

Taxes on income

(125)

Depreciation

2,975

Adjustment to revenues of the Talmei Yosef project due to calculation based on the
fixed asset model

3,023

Share-based payments

50

Adjusted EBITDA as defined the Series C Deed of Trust

3,389

Information for the Company's Series D Debenture Holders

The Deed of Trust governing the Company's Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of December 31, 2020, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately €117.5 million and (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's consolidated shareholders' equity plus the Net Financial Debt) was 5.1% and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA (as defined in the Series D Deed of Trust(1)) was 1.6.

______________________________________________
(1) The term "Adjusted EBITDA" is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef project, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

The following is a reconciliation between the Company's profit (loss) and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended December 31, 2020:


For the four
quarter period
ended
December 31,
2020


Unaudited


in thousands

Profit (loss) for the period

(6,168)

Financing expenses, net

3,634

Taxes on income

(125)

Depreciation

2,975

Adjustment to revenues of the Talmei Yosef project due to calculation based on the
fixed asset model

3,023

Share-based payments

50

Adjustment to data relating to projects with a Commercial Operation Date during the
four preceding quarters*

384

Adjusted EBITDA as defined the Series D Deed of Trust

3,773

________________________
* Based on the internal calculation of EBITDA of the biogas plant in Gelderland, the Netherlands since the acquisition date (December 1, 2020). These results were not included in the profit and loss statement of the Company for the year ended December 31, 2020.

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/ellomay-capital-reports-results-for-the-fourth-quarter-and-full-year-of-2020-301259977.html

SOURCE Ellomay Capital Ltd